Alexander Gaber (Former)
1 – 33 of 33
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer.
(
- Contribution to journal › Article
- 2019
-
Mark
Expression of tSTAT3, pSTAT3
727
, and pSTAT3
705
in the epithelial cells of hormone-naïve prostate cancer
(
- Contribution to journal › Article
- 2018
-
Mark
MMP7 modulation by short- and long-term radiotherapy in patients with rectal cancer
(
- Contribution to journal › Article
- 2017
-
Mark
Therapeutic rationale to target highly expressed CDK7 conferring poor outcomes in triple-negative breast cancer
(
- Contribution to journal › Article
- 2016
-
Mark
Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.
(
- Contribution to journal › Article
- 2015
-
Mark
S100A9 expressed in ER(-)PgR(-) breast cancers induces inflammatory cytokines and is associated with an impaired overall survival.
(
- Contribution to journal › Article
-
Mark
Low RBM3 Protein Expression Correlates with Clinical Stage, Prognostic Classification and Increased Risk of Treatment Failure in Testicular Non-Seminomatous Germ Cell Cancer.
(
- Contribution to journal › Article
- 2014
-
Mark
Reduced expression of the polymeric immunoglobulin receptor in pancreatic and periampullary adenocarcinoma signifies tumour progression and poor prognosis
(
- Contribution to journal › Article
-
Mark
Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts.
(
- Contribution to journal › Article
-
Mark
Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker.
(
- Contribution to journal › Article
-
Mark
Expression and prognostic significance of the polymeric immunoglobulin receptor in esophageal and gastric adenocarcinoma.
(
- Contribution to journal › Article
-
Mark
High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death.
(
- Contribution to journal › Article
-
Mark
SATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinoma.
(
- Contribution to journal › Article
-
Mark
Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients.
(
- Contribution to journal › Article
-
Mark
Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma
(
- Contribution to journal › Article
- 2013
-
Mark
Histological specificity of alterations and expression of KIT and KITLG in non-small cell lung carcinoma.
(
- Contribution to journal › Article
-
Mark
Detecting EGFR alterations in clinical specimens-pitfalls and necessities.
(
- Contribution to journal › Article
- 2012
-
Mark
Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
(
- Contribution to journal › Article
-
Mark
Prognostic role of tumour associated trypsin inhibitor in colorectal cancer patients
(
- Thesis › Doctoral thesis (compilation)
-
Mark
A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer
(
- Contribution to journal › Article
-
Mark
Gender, anthropometric factors and risk of colorectal cancer with particular reference to tumour location and TNM stage : A cohort study
(
- Contribution to journal › Article
- 2011
-
Mark
Effects of radiation therapy on tissue and serum concentrations of tumour associated trypsin inhibitor and their prognostic significance in rectal cancer patients
(
- Contribution to journal › Article
-
Mark
Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis.
2011) In Modern Pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 24. p.708-719(
- Contribution to journal › Article
-
Mark
Cyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort study.
(
- Contribution to journal › Article
-
Mark
High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer
(
- Contribution to journal › Article
-
Mark
Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer.
(
- Contribution to journal › Article
-
Mark
AUTOMATED IMAGE ANALYSIS CONFIRMS THE PREDICTIVE SIGNIFICANCE OF MSMB IN PROSTATE CANCER
(
- Contribution to journal › Published meeting abstract
-
Mark
High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression.
(
- Contribution to journal › Article
- 2010
-
Mark
Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.
(
- Contribution to journal › Article
- 2009
-
Mark
High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer.
(
- Contribution to journal › Article
- 2008
-
Mark
HMG-CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors.
(
- Contribution to journal › Article